Gujarat Kidney & Super Speciality IPO GMP & Review: Apply or Avoid?
Posted by : sachet | Fri Dec 19 2025
Gujarat Kidney & Super Speciality IPO is open for bidding from 22nd December 2025 to 24th December 2025. It is a bookbuilding IPO of ₹250.80 crore, an entirely fresh issue of 2.20 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 30th December 2025.
Gujarat Kidney Super Speciality IPO Details
The Gujarat Kidney Super Speciality IPO date is fixed between 22nd December 2025 and 24th December 2025. The face value of Gujarat Kidney & Super Speciality shares stands at ₹2 per share, and the IPO Issue price band is set at ₹108 to ₹114 per share
MUFG Intime India Limited is the registrar of the Gujarat Kidney & Super Speciality IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below.
| IPO Allotment Date | 26th December 2025 |
| IPO Open Date | 22nd December 2025 |
| IPO Close Date | 24th December 2025 |
| Refund Initiation | 29th December 2025 |
| Issue Size | 2,20,00,000 shares(agg. up to ₹250.80 Cr) |
| Face Value | ₹2 per share |
| Lot Size | 128 Shares |
| Issue Price | ₹108 to ₹114 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE NSE |
| Listing Date | 30th December 2025 |
Gujarat Kidney Super Speciality IPO Share Reservation
Riddhi Display Equipment’s IPO is a bookbuilding IPO issue of 2.20 crore worth ₹250.80 crores. Gujarat Kidney & Super Speciality IPO Limited shares will be listed on the BSE and the NSE Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories.
| Investor Categories | Shares Offered |
| QIB shares offered | Not less than 75% of the Issue |
| NII (HNI) Shares Offered | Not more than 15% of the Issue |
| Retail Shares Offered | Not more than 10% of the Issue |
Gujarat Kidney Super Speciality IPO GMP Grey Market Premium
GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Gujarat Kidney & Super Speciality IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 24-12-2025 | – | – | – | – |
| 23-12-2025 | – | – | – | – |
| 22-12-2025 | ₹114.00 | ₹8.00 | ₹122.00 | 7.02% |
| 21-12-2025 | ₹114.00 | ₹8.00 | ₹122.00 | 7.02% |
| 20-12-2025 | ₹114.00 | ₹8.00 | ₹122.00 | 7.02% |
| 19-12-2025 | ₹114.00 | ₹8.00 | ₹122.00 | 7.02% |
| 18-12-2025 | ₹114.00 | ₹10.00 | ₹124.00 | 8.77% |
| 17-12-2025 | ₹114.00 | ₹0.00 | ₹86.00 | 0.00% |
| 16-12-2025 | ₹114.00 | ₹0.00 | ₹86.00 | 0.00% |
| 15-12-2025 | ₹114.00 | ₹0.00 | ₹86.00 | 0.00% |
As of 22nd December 2025, Gujarat Kidney & Super Speciality IPO GMP stands at ₹8 per share, which means the share will likely show a listing at ₹122.00 on its tentative listing date, 30th December 2025.
GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Gujarat Kidney & Super Speciality IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends.
Gujarat Kidney Super Speciality IPO GMP Review
Check out the detailed Gujarat Kidney & Super Speciality GMP IPO review for a thorough understanding of its potential to report listing gains on 30th December 2025. The Gujarat Kidney & Super Speciality IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO.
Financial Health
Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Gujarat Kidney & Super Speciality IPO.
Gujarat Kidney & Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024 to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.
Gujarat Kidney & Super Speciality’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, the brokers, investors, and RAs have a positive outlook for the Gujarat Kidney & Super Speciality IPO for its tentative listing day, which is 30th December 2025.
Technical Analysis
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Gujarat Kidney & Super Speciality IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 61.62 |
| EPS (Earnings Per Share) | 1.85 |
| RoNW | 36.61% |
| ROCE | 37.65% |
| ROE | 36.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
| Market Capitalisation | ₹898.81 Cr |
The PE ratio of Gujarat Kidney & Super Speciality Limited shares is 61.62, and its Earnings Per Share (EPS) stands at 1.85. Thus, the Gujarat Kidney & Super Speciality IPO can deliver gains on its tentative listing date, 30th December 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Gujarat Kidney & Super Speciality Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 61.62 | 41.59 |
| EPS | 1.85 | 2.74 |
Gujarat Kidney Super Speciality IPO Subscription Status
The Gujarat Kidney Super Speciality IPO is to be opened for bidding on 22nd December 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Gujarat Kidney & Super Speciality IPO Subscription Status.
| Investor Categories | Shares Offered | Shares Subscribed | Subscription to the Times |
| QIB shares offered | Not less than 75% of the Issue | Yet to be announced | Yet to be announced |
| NII (HNI) Shares Offered | Not more than 15% of the Issue | Yet to be announced | Yet to be announced |
| Retail Shares Offered | Not more than 10% of the Issue | Yet to be announced | Yet to be announced |
About Gujarat Kidney Super Speciality Limited
Gujarat Kidney & Super Speciality was established in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India. The company operates seven multispeciality hospitals and four pharmacies, with a total bed capacity of 490, an approved capacity of 455, and an operational capacity of 340. The company’s hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Gujarat Kidney Super Speciality Limited Financials
The company’s financial analysis is essential before applying for the Gujarat Kidney & Super Speciality IPO. Look at the table to learn about Gujarat Kidney & Super Speciality Limited’s financials.
| Year Ended | 30th June 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Revenue | 15.27 | 40.40 | 5.48 | 0.00 |
| Profit After Tax | 5.40 | 9.50 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| Net Worth | 30.56 | 25.71 | 10.80 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.60 | 0.17 |
| Total Borrowings | 4.03 | 3.88 | 1.94 | – |
Explanation
Gujarat Kidney & Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024 to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.
Gujarat Kidney Super Speciality Limited IPO Promoter Holdings
Have a look at the table below to check the holdings of Gujarat Kidney & Super Speciality Limited.
Mr Hitesh Kumar Singla, Mr Nikhil Singla, Mr Nitin Dixit, and Mr Anil Kumar Sharma.
| Shareholding Pre-Issue | 99.10% |
| Shareholding Post-Issue | 71.45% |
Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.
Aim of Gujarat Kidney Super Speciality IPO
The primary aim of the Gujarat Kidney Super Speciality IPO is to raise ₹250.80 crores. On the other hand, Gujarat Kidney & Super Speciality has decided to utilise these funds in different ways.
- The proposed acquisition of Parekhs Hospital at Ahmedabad.
- To Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”.
- To fund the capital expenditure requirements of the Company towards setting up a new hospital in Vadodara.
- To buy robotics equipment for our hospital, Gujarat Kidney & Super Speciality Hospital in Vadodara.
- To Full or partial repayment and/or prepayment of certain outstanding secured borrowings availed by the Company
- To fund inorganic growth through unidentified acquisitions and General Corporate Purposes.
- To acquire additional shareholding in the subsidiary, namely “Harmony Medicare Private Limited” at Bharuch
Should I Invest in the Gujarat Kidney Super Speciality IPO?
Explore the pros and cons of Gujarat Kidney & Super Speciality to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades.
Pros of Gujarat Kidney Super Speciality IPO
- The company has Preeminence in renal sciences, with established sub-specialities in urology.
- The company has an asset-light business model focused on the central region of Gujarat.
- The company has the Ability to attract, retain, and recruit skilled and experienced quality medical professionals.
- The Track record of operating and financial performance and growth
Cons of Gujarat Kidney Super Speciality IPO
- The company has a dependence on acquisitions & integration risks
- The company has a limited operating track record
- The company has execution risks with expansion projects
How to Apply for Gujarat Kidney Super Speciality IPO?
Check the steps mentioned below to apply for Gujarat Kidney & Super Speciality Ltd.
- Step 1: Conduct thorough research on the Gujarat Kidney & Super Speciality IPO GMP, subscription status, issue size, lot size, and other details.
- Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section.
- Step 3: Make a bid for 1 lot of 128 shares worth ₹14,592
- Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.
Note: You can apply for the Gujarat Kidney & Super Speciality IPO across multiple demat accounts to increase your chances of allotment.
How to Check Gujarat Kidney & Super Speciality IPO Allotment Status?
You can check for the Gujarat Kidney & Super Speciality IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.
Check On NSE
- Visit the NSE Official Site
- Navigate to the IPO Allotment Section.
- Select Equity as the issue type.
- Choose the Gujarat Kidney & Super Speciality IPO.
- Choose whether to proceed with the PAN number or the application number.
- Submit your details to get the allotment status online.
Check On the Registrar Portal
- Visit the registrar portal.
- Click on the allotment option.
- Fill in the required details.
- Click on the submit button to know your Gujarat Kidney & Super Speciality IPO allotment status.
Let’s Wrap
Gujarat Kidney & Super Speciality IPO is a bookbuilding issue of shares worth ₹250.80 crores. The shares of Gujarat Kidney & Super Speciality Limited will be listed on BSE and NSE on its tentative listing date of 30th December 2025. Researching the Gujarat Kidney & Super Speciality IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.
Open a demat account on Univest now to initiate your investment journey!
FAQs on Gujarat Kidney & Super Speciality IPO
How is the Gujarat Kidney & Super Speciality IPO?
Ans. Currently, on 22nd December 2025, the Gujarat Kidney & Super Speciality GMP (Grey Market Premium) stands at ₹8. It indicates that the estimated listing price could be ₹122 per share. It is a bookbuilding IPO of ₹250.80 shares. The face value of each Gujarat Kidney & Super Speciality share is ₹2 per share.
What is the Gujarat Kidney & Super Speciality IPO price?
Ans. The Gujarat Kidney & Super Speciality IPO issue price band is set at ₹108.00 to ₹114.00 per share.
Is the Gujarat Kidney & Super Speciality IPO a good investment?
Ans. Gujarat Kidney & Super Speciality Limited’s revenue increased by 637% from ₹5.48 crores in March 2024 to ₹40.40 crores in March 2025. Moreover, the company’s PAT increased by 454% from ₹1.71 crores in March 2024 to ₹9.50 crores in March 2025.
Who is the registrar of the Gujarat Kidney & Super Speciality IPO?
Ans. MUFG Intime India Private Limited is the registrar for the Gujarat Kidney & Super Speciality IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Gujarat Kidney & Super Speciality allotment and refund, you can contact MUFG Intime India Private Limited at gujaratkidney.ipo@in.mpms.mufg.com or at +91-22-4918 6270.
What is the issue size of the Gujarat Kidney & Super Speciality IPO?
Ans. Gujarat Kidney & Super Speciality IPO is a bookbuilding IPO for ₹250.80 shares. Moreover, the IPO is set to open on 22nd December 2025 and will be closed on 24th December 2025.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Gujarat Kidney & Super Speciality IPO, download the Gujarat Kidney & Super Speciality IPO RHP and Gujarat Kidney & Super Speciality IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Upcoming IPOs
| IPO Names | Expected Year of IPO |
| PhonePe IPO | 2025 |
| Bajaj Energy IPO | 2025 |
| OYO IPO | 2025 |
| NSDL IPO | 2025 |
| Flipkart IPO | 2025 |
| Zepto IPO | 2025 |
| Boat IPO | 2025 |
| Meesho IPO | 2025 |
| Jio IPO | 2026 |
| NSE IPO | 2025 |
Current & Previous IPOs
| Company | IPO Open | IPO Close | Type |
| Anthem Biosciences Limited | 14th July 2025 | 16th July 2025 | Mainboard |
| Spunweb Nonwoven Limited | 14th July 2025 | 16th July 2025 | SME |
| Smartworks Coworking Spaces Limited | 10th July 2025 | 14th July 2025 | Mainboard |
| CFF Fluid Control Limited | 9th July 2025 | 11th July 2025 | SME |
| GLEN Industries Limited | 8th July 2025 | 10th July 2025 | SME |
| Chemkart India Limited | 7th July 2025 | 9th July 2025 | SME |
| Travel Food Services Limited | 7th July 2025 | 9th July 2025 | Mainboard |
| Smarten Power Systems Limited | 7th July 2025 | 9th July 2025 | SME |
| Meta Infotech Limited | 4th July 2025 | 8th July 2025 | SME |
| Cryogenic OGS Limited | 3rd July 2025 | 7th July 2025 | SME |
| Happy Square Outsourcing Services Limited | 3rd July 2025 | 7th July 2025 | SME |
| Crizac Limited | 3rd July 2025 | 7th July 2025 | Mainboard |
| Silky Overseas Limited | 30th June 2025 | 2nd July 2025 | SME |
| Pushpa Jewellers Limited | 30th June 2025 | 2nd July 2025 | SME |
| Cedaar Textile Limited | 30th June 2025 | 2nd July 2025 | SME |
| Marc Loire Fashions Limited | 30th June 2025 | 2nd July 2025 | SME |
Read Our Articles on the Best Stocks
Tech Stocks in India to Invest in 2025 | Tech Sector Stocks
Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks
Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks
Paint Stocks in India to Invest in 2025 | Paint Sector Stocks
Paper Stocks in India to Invest in 2025 | Paper Sector Stocks
Best Semiconductor Stocks in India 2025
Best Large Cap Stocks in India 2025
Best Cement Stocks To Invest In India
Also Explore
Univest Screeners
Explore Webstories on Univest
Best Time To Buy Dividend Stocks
How RBI Policies Affect Dividend Stocks
Can Dividend Stocks Beat Inflation
What Is The Dividend Aristocrat List
